CEO: Jay R. Luly

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Enanta Pharmaceuticals Inc is a biotechnology company. It is engaged in the research and development of small molecule drugs for infectious diseases. The Group uses its chemistry-driven approach & drug discovery capabilities to develop its products.


Key numbers

Market Capitalization:1215757140
Shares Outstanding: 19682000
Float: 17370231.008
Next Earning Date:2019-11-21
TTm EPS: 3.3235
TTm Dividend Rate:
200 days moving average:81.78
50 days moving average: 63.55
One day percent Change: 0.24



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-09-30, 2016-09-30, 2017-09-30, 2018-09-30,
2015-09-30, 2016-09-30, 2017-09-30, 2018-09-30,